The GHIT Fund is a Japan-based international public-private partnership (PPP) fund that was formed between the Government of Japan, multiple pharmaceutical companies, the Gates Foundation, Wellcome, and the United Nations Development Programme (UNDP). The GHIT Fund invests in and manages an R&D portfolio of development partnerships aimed at addressing neglected diseases, such as malaria, tuberculosis, and neglected tropical diseases, which afflict the world’s vulnerable and underserved populations. In collaboration with global partners, the GHIT Fund mobilizes Japanese industry, academia, and research institutes to create new drugs, vaccines, and diagnostics for malaria, tuberculosis, and neglected tropical diseases.
- About AVPN
-
-
-
About AVPN
Who We Are
AVPN is Asia’s largest platform for social impact, where over 700 resource providers, innovators and intermediaries from across 43 markets collaborate to mobilise capital. Grounded in deep regional expertise and partnerships, AVPN is building a thriving ecosystem that accelerates measurable progress toward inclusive growth, empowering Asia to lead the way in global impact.
Annual Review
AVPN has empowered its community to connect, learn, act, and lead in advancing social impact in Asia. Take a look at our interactive Annual Review to learn more about our work and impact.
-
-
-
- Impact Areas
-
-
-
Impact Area
SIGNATURE THEMATIC PRODUCTS
SPECIAL INITIATIVES
Thematic Products
Driving Asian leadership in climate agenda by channeling more resources into climate action.
Mobilising capital to improve outcomes for women and girls in Asia.
A collaborative space to scale policy action and implement solutions for health equity across Asia.
Equipping the next generation of Asian youths with the capital and resources they need to drive impactful change.
-
-
-
